The current standard of care for HCV is a combination of PEGylated ... Telaprevir-based Regimen in Genotype 1 Hepatitis C Patients Who Failed Prior Treatment. Vertex web site [online], (2008).
for treatment of hepatitis C virus (HCV) met its primary endpoints of safety and sustained virologic response at 12 weeks post-treatment (SVR12). Primary endpoint results demonstrated a 98% (208/213) ...
Screening for Hepatitis ... C disease. According to a study published in the Canadian Medical Association Journal, almost half of the women infected with HCV are unaware of their infection ...
People with co-infection may particularly benefit from early treatment because having well-controlled HIV and restored immune function reduces the risk of liver disease progression. Current guidelines ...
Also, the compounds and treatment strategies developed for ... the treatment of other viral infections, in particular hepatitis C virus (HCV). Although HCV is fundamentally different to HIV ...
Worldwide, the hepatitis C virus infects an estimated 130-150 million ... more strategically about the benefits of more proactive HCV treatment. Higher upfront costs need to be weighed against ...
She was fortunate to take the treatment that essentially cures humans of hepatitis C before the virus could wreak significant havoc on her body. “The doctor at the virology clinic was pretty ...
Hepatitis C is a contagious liver disease caused by the hepatitis C virus, or HCV. In some cases, the virus causes a long lasting infection. When that happens, inflammation from the infection ...
This article demonstrates how introducing a new way of testing prisoners for hepatitis C in a busy remand prison identifies the infection quicker. Benefits of this include quicker access to curative ...